跳至主要内容
临床试验/NCT00922337
NCT00922337已完成不适用

A Prospective, Observational, Multicenter Registry To Evaluate the 'Real World' Clinical Performance of the MGuard Coronary Stent System

InspireMD2 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2009年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
InspireMD
入组人数
86
试验地点
2
主要终点
Major Cardiac Adverse Events rate (MACE)

研究概览

简要总结

the objective of the Israeli MGurad Registry is to evaluate the 'Real World' Clinical Performance of the InspireMD MGuard Coronary Stent System

详细描述

A Prospective, Observational, Multicenter Registry The primary objective of this registry is to document the safety and overall clinical performance of the MGuard Coronary Stent System in a "real world" patient population requiring stent implantation.

The secondary objective is to assess the event rate in patient subgroups with specific clinical indications and/or vessel and/or lesion characteristics.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is > 18 years of age
  • The patient has consented to participate by signing the "Patient Informed Consent Form"
  • Patient is suitable for implantation of one or more MGuard Stent System in one or more target lesions
  • Target lesion(s) are according to the Indications for Use and Israeli regulatory approval of the MGuard Stent System
  • The patient is willing and able to cooperate with registry procedures and required follow up

排除标准

  • Heavily calcified target lesions
  • Target lesions with side branch bigger then 2.5mm
  • Target lesions which are distal to newly stented lesion (less than 1 month).
  • Women with known pregnancy
  • Current medical condition with a life expectancy of less than 12 months
  • Patients with medical conditions that preclude the follow-up as defined in the protocol or that otherwise limits study participation

结局指标

主要结局

Major Cardiac Adverse Events rate (MACE)

时间窗: 1 month

次要结局

  • Lesion success rate(1 day)
  • Major Cardiac Adverse Events rate (MACE)(6 months)
  • Bleeding complications(6 months)
  • Stent thrombosis rate(6 months)
  • Any death(6 months)

研究者

发起方
InspireMD
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验